Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hyperbaric Oxygen Therapy for Peripheral Neuropathy Due to Paclitaxel Analogs

NCT06819501 is registered in ClinicalTrials.gov with Guangdong Provincial People's Hospital as lead sponsor.

NCT NCT06819501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06819501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hyperbaric Oxygen Therapy for Peripheral Neuropathy Due to Paclitaxel Analogs
Lead sponsor
Guangdong Provincial People's Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
February 5, 2025
Completion date
September 1, 2026
Enrollment
226 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancers